相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer
Sumiyuki Nishida et al.
JOURNAL OF IMMUNOTHERAPY (2022)
WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine
Shouq Alzaaqi et al.
ONCOLOGY LETTERS (2022)
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides
Fumihiro Fujiki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
Lingling Chen et al.
CLINICAL CANCER RESEARCH (2020)
Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival
Michael Dietachmayr et al.
NATURE COMMUNICATIONS (2020)
Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia
Tomohiro Matsuda et al.
CANCER EPIDEMIOLOGY (2020)
Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling
Yun Han et al.
CELL CYCLE (2020)
Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)
Paolo G. Casali et al.
ESMO OPEN (2020)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines
Shuichi Hanada et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma
Akihiro Tsuboi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Future Approaches to Precision Oncology-Based Clinical Trials
Arjun Mittra et al.
CANCER JOURNAL (2019)
WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies
Yusuke Oji et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
Sumiyuki Nishida et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides
Jun Nakata et al.
Oncotarget (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sebastien Anguille et al.
BLOOD (2017)
Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells
Hans Jiro Becker et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
Yusuke Oji et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
Hee Jin Lee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The paradoxical role of IL-10 in immunity and cancer
Mark H. Mannino et al.
CANCER LETTERS (2015)
Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair
Yusuke Oji et al.
MOLECULAR CARCINOGENESIS (2015)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses
Liang Zhang et al.
BLOOD (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
Y. Hashii et al.
LEUKEMIA (2012)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
Toshiki Ochi et al.
BLOOD (2011)
Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer
Luc de Chaisemartin et al.
CANCER RESEARCH (2011)
The Occurrence of Rare Cancers in US Adults, 1995-2004
Robert T. Greenlee et al.
PUBLIC HEALTH REPORTS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
Shuichi Izumoto et al.
JOURNAL OF NEUROSURGERY (2008)
Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
K. Ito et al.
ONCOGENE (2006)
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
T Jomgeow et al.
CANCER SCIENCE (2006)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
Y Oji et al.
CANCER SCIENCE (2004)
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
Y Oji et al.
CANCER SCIENCE (2004)
Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
Y Oji et al.
CANCER SCIENCE (2003)
Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
T Ueda et al.
CANCER SCIENCE (2003)
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers
Y Oji et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
Y Oka et al.
IMMUNOGENETICS (2000)
分享论文
